The selection of a research site is one of the key stages in the preparation of a clinical trial. The quality of the selected research site has a significant impact on patient recruitment timelines, the quality of collected data, compliance with Good Clinical Practice (GCP) requirements, participant safety, and the successful completion of the project.

An insufficient assessment of a site's capabilities may result in delays in patient or volunteer recruitment, an increased number of protocol deviations, unsatisfactory monitoring results, and even the exclusion of site data from the final analysis. Therefore, sponsors and Contract Research Organizations (CROs) conduct a comprehensive assessment of potential research sites before the study begins.

What Is a Research Site?
A research site is a medical organization where a clinical trial is conducted in accordance with the approved protocol, applicable legislation, and the principles of Good Clinical Practice (GCP).
Research sites may include:

• public multidisciplinary hospitals;
• federal medical centers;
• research institutes;
• university hospitals;
• private healthcare organizations with the necessary infrastructure and experience in conducting clinical trials.

At each site, the Principal Investigator (PI) is responsible for the conduct of the study. The PI manages the research team and ensures compliance with the protocol, protection of study participants' rights, and the quality of the data collected.

Why Is Research Site Selection Critical?
Even a perfectly designed clinical trial protocol cannot ensure reliable results if the research site lacks sufficient experience, qualified personnel, or the necessary resources.
The quality of the site's performance directly affects:

• the speed of patient enrollment;
• the completeness and accuracy of source medical documentation;
• the quality of completion of electronic Case Report Forms (eCRFs) for patients or volunteers;
• the number of protocol deviations;
• successful completion of monitoring visits, audits, and inspections;
• the safety of study participants.

According to the principles of ICH GCP E6(R3), the sponsor must ensure that the investigator and research site have sufficient qualifications, experience, and resources to conduct the clinical trial.

Key Criteria for Research Site Selection
Experience in Conducting Clinical Trials
One of the first criteria assessed is the site's experience in clinical research.
The following factors are typically reviewed:

• the number of completed clinical trials and the number of medicinal products registered following those trials;
• experience in conducting trials across different phases;
• experience in the relevant therapeutic area;
• participation in international multicenter projects;
• the site's track record in audits and inspections.

An experienced research site is generally more familiar with GCP requirements, can organize study processes more efficiently, and is less likely to make errors in documentation and protocol-required procedures.

Patient/Volunteer Recruitment Potential
For most clinical trials, the speed of patient recruitment is one of the key factors determining the successful implementation of the project.
During the site assessment, the following factors are analyzed:

• the number of potential patients;
• the patient flow and its structure;
• epidemiological data related to the disease;
• the availability of specialized departments;
• the ability to identify potential patients through medical information systems;
• previous recruitment performance.

Overestimating a site's recruitment capabilities creates the risk of insufficient enrollment, which may extend the study timeline and increase costs.

Qualifications of the Research Team
The sponsor evaluates not only the Principal Investigator but also the entire research team at the site.
The following aspects are reviewed:

• education and professional qualifications;
• GCP certificates;
• experience in clinical research;
• publication activity;
• participation in professional communities;
• allocation of responsibilities within the research team.

Infrastructure and Technical Capabilities
A modern research site must have the infrastructure necessary to perform all study-related procedures.
The assessment may include:

• rooms for study participant visits;
• facilities for storage of the investigational medicinal product;
• refrigeration equipment with continuous temperature monitoring;
• facilities for archiving study documentation;
• equipment required for diagnostic procedures;
• laboratory facilities;
• backup power supply systems;
• personal data protection measures.

When necessary, a pre-study site visit may be conducted, during which representatives of the sponsor or CRO assess the site's readiness to conduct the clinical trial.

Quality Management System
Particular attention is paid to the site's internal quality management system.
The assessment may include the availability of:

• Standard Operating Procedures (SOPs);
• a staff training system;
• procedures for recording protocol deviations;
• documentation processes;
• a Corrective and Preventive Action (CAPA) system;
• internal quality control procedures.

A mature quality management system reduces the likelihood of critical findings and serious compliance issues during the clinical trial.

Audit and Inspection History
When selecting a research site, the results of previous:

• internal audits;
• sponsor audits;
• regulatory inspections

are analyzed.
Particular attention is paid to critical and major findings, as well as the effectiveness of the corrective and preventive actions (CAPA) implemented in response to them.
The presence of isolated findings is not necessarily a reason to reject a site if the site has addressed the identified deficiencies in a timely and effective manner.

Why Does CRO Experience Matter?
A Contract Research Organization plays an important role in the selection of research sites. An experienced CRO has its own database of qualified and previously assessed sites and understands their strengths and weaknesses, recruitment performance, results from previous projects, and history of cooperation with sponsors.
This makes it possible to shorten study start-up timelines, reduce the risk of errors when selecting a research site, and ensure more effective project management.


Research site selection is a multi-stage process that includes an assessment of experience, human resources, infrastructure, recruitment potential, and the site's quality management system. A comprehensive assessment of a research site helps minimize risks associated with conducting a clinical trial, ensure compliance with GCP requirements, and generate reliable data suitable for subsequent evaluation of the efficacy and safety of the investigational medicinal product.

For sponsors and CROs, the correct selection of research sites is a strategic decision that directly affects project timelines, data quality, and the successful completion of audits and regulatory inspections.